troxipide

Uses your system voice; voice and rate in settings.

Q4381806Snapshot

≈ 1 min read

Names in other languages

  • РусскийПротивоязвенные препараты и препараты для лечения гастроэзофагеального рефлюкса
  • العربيةتروكسيبيد
  • Englishtroxipide
  • eutroxipida
  • shTroksipid
  • sltroksipid
  • СрпскиTroksipid

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Troxipide is a drug used in the treatment of gastroesophageal reflux disease. Troxipide is a systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. Troxipide is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis.

Troxipide is a drug used in the treatment of gastroesophageal reflux disease. Troxipide is a systemic non-antisecretory gastric cytoprotective agent with anti-ulcer, anti-inflammatory and mucus secreting properties irrespective of pH of stomach or duodenum. Troxipide is currently marketed in Japan (Aplace), China (Shuqi), South Korea (Defensa), and India (Troxip). It is used for the management of gastric ulcers, and amelioration of gastric mucosal lesions in acute gastritis and acute exacerbation of chronic gastritis.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1370866684 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.